Adult Acute Myeloid Leukemia With t(16;16)(p13.1;q22); CBFB-MYH11

specific

An acute myeloid leukemia with t(16;16)(p13.1;q22); CBFB-MYH11 occurring in adults.

Centers

Active Trials

—

Cancer Funding

Top Centers for Adult Acute Myeloid Leukemia With t(16;16)(p13.1;q22); CBFB-MYH11(64)

Ranked by research excellence score (trials · grants · publications). Methodology →

#	Center	Research Tier	Active Trials	Cancer Funding	Score
1	Fred Hutch Cancer CenterSeattle, WA NCI Comprehensive Active Research Program	Active Research Program	1	—	68.0
2	University of Michigan Rogel Cancer CenterAnn Arbor, MI NCI Comprehensive Active Research Program	Active Research Program	1	—	68.0
3	Stanford Cancer InstitutePalo Alto, CA NCI Comprehensive Active Research Program	Active Research Program	1	—	68.0
4	The University of Texas MD Anderson Cancer CenterHouston, TX NCI Comprehensive Active Research Program	Active Research Program	1	—	68.0
5	The Ohio State University Comprehensive Cancer Center - James Cancer Hospital & Solove Research InstituteColumbus, OH NCI Comprehensive Active Research Program	Active Research Program	1	—	68.0
6	UC Davis Comprehensive Cancer CenterSacramento, CA NCI Comprehensive Active Research Program	Active Research Program	1	—	68.0
7	Sylvester Comprehensive Cancer CenterMiami, FL NCI Clinical Active Research Program	Active Research Program	1	—	68.0
8	Cleveland Clinic Cancer CenterCleveland, OH Active Research Program	Active Research Program	1	—	68.0
9	The University of Kansas Cancer CenterKansas City, KS NCI Comprehensive Active Research Program	Active Research Program	1	—	68.0
10	University of Illinois Cancer CenterChicago, IL Active Research Program	Active Research Program	1	—	68.0
11	University of New Mexico Comprehensive Cancer CenterAlbuquerque, NM NCI Comprehensive Active Research Program	Active Research Program	1	—	68.0
12	Karmanos Cancer InstituteDetroit, MI NCI Comprehensive Active Research Program	Active Research Program	1	—	68.0
13	Cancer Center at IllinoisUrbana, IL Active Research Program	Active Research Program	1	—	68.0
14	University of Cincinnati Cancer CenterCincinnati, OH Active Research Program	Active Research Program	1	—	68.0
15	Louisiana Cancer Research CenterNew Orleans, LA Active Research Program	Active Research Program	1	—	68.0
16	Memorial Sloan Kettering Cancer CenterNew York, NY NCI Comprehensive		—	—	45.5
17	Dana-Farber Cancer InstituteBoston, MA NCI Comprehensive		—	—	45.5
18	Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins UniversityBaltimore, MD NCI Comprehensive		—	—	45.5
19	Abramson Cancer Center of the University of PennsylvaniaPhiladelphia, PA NCI Comprehensive		—	—	45.5
20	UNC Lineberger Comprehensive Cancer CenterChapel Hill, NC NCI Comprehensive		—	—	45.5
21	Mayo Clinic Comprehensive Cancer CenterRochester, MN NCI Comprehensive		—	—	45.5
22	Yale Cancer Center Yale School of MedicineNew Haven, CT NCI Comprehensive		—	—	45.5
23	Vanderbilt-Ingram Cancer CenterNashville, TN NCI Comprehensive		—	—	45.5
24	Herbert Irving Comprehensive Cancer CenterNew York, NY NCI Comprehensive		—	—	45.5
25	Dan L Duncan Comprehensive Cancer Center at Baylor College of MedicineHouston, TX NCI Comprehensive		—	—	45.5
26	Duke Cancer InstituteDurham, NC NCI Comprehensive		—	—	45.5
27	The University of Chicago Medicine Comprehensive Cancer CenterChicago, IL NCI Comprehensive		—	—	45.5
28	Simmons Comprehensive Cancer Center UT Southwestern Medical CenterDallas, TX NCI Comprehensive		—	—	45.5
29	Laura and Isaac Perlmutter Cancer Center at NYU Langone HealthNew York, NY NCI Comprehensive		—	—	45.5
30	Winship Cancer InstituteAtlanta, GA NCI Comprehensive		—	—	45.5
31	Masonic Cancer CenterMinneapolis, MN NCI Comprehensive		—	—	45.5
32	University of Colorado Cancer CenterAurora, CO NCI Comprehensive		—	—	45.5
33	Moffitt Cancer CenterTampa, FL NCI Comprehensive		—	—	45.5
34	Huntsman Cancer Institute at the University of UtahSalt Lake City, UT NCI Comprehensive		—	—	45.5
35	Case Comprehensive Cancer CenterCleveland, OH NCI Comprehensive		—	—	45.5
36	UF Health Cancer InstituteGainesville, FL NCI Clinical		—	—	45.5
37	Roswell Park Comprehensive Cancer CenterBuffalo, NY NCI Comprehensive		—	—	45.5
38	University of Virginia Cancer CenterCharlottesville, VA NCI Comprehensive		—	—	45.5
39	The University of Arizona Cancer CenterTucson, AZ NCI Comprehensive		—	—	45.5
40	Medical College of Wisconsin Cancer CenterMilwaukee, WI		—	—	45.5
41	Cedars-Sinai CancerLos Angeles, CA		—	—	45.5
42	Holden Comprehensive Cancer CenterIowa City, IA NCI Comprehensive		—	—	45.5
43	Fred & Pamela Buffett Cancer CenterOmaha, NE NCI Clinical		—	—	45.5
44	Sidney Kimmel Comprehensive Cancer Center at JeffersonPhiladelphia, PA NCI Comprehensive		—	—	45.5
45	Dartmouth Cancer CenterLebanon, NH NCI Comprehensive		—	—	45.5
46	Rutgers Cancer InstituteNew Brunswick, NJ NCI Comprehensive		—	—	45.5
47	University of Hawai‘i Cancer CenterHonolulu, HI NCI Clinical		—	—	45.5
48	UAMS Winthrop P. Rockefeller Cancer InstituteLittle Rock, AR		—	—	45.5
49	Fox Chase Cancer CenterPhiladelphia, PA NCI Comprehensive		—	—	45.5
50	Boston University Cancer CenterBoston, MA		—	—	45.5
51	Houston Methodist Dr. Mary and Ron Neal Cancer CenterHouston, TX		—	—	45.5
52	Stony Brook Cancer CenterStony Brook, NY		—	—	45.5
53	Penn State Cancer InstituteHershey, PA		—	—	45.5
54	Mayo Clinic Comprehensive Cancer Center, FloridaJacksonville, FL		—	—	45.5
55	Mayo Clinic Comprehensive Cancer Center, ArizonaScottsdale, AZ		—	—	45.5
56	Georgia Cancer Center, Augusta UniversityAugusta, GA		—	—	45.5
57	The University of Vermont Cancer CenterBurlington, VT		—	—	45.5
58	University of Puerto Rico Comprehensive Cancer CenterSan Juan, PR		—	—	45.5
59	Northwell Health Cancer InstituteNew York, NY		—	—	45.5
60	Upstate Cancer CenterSyracuse, NY		—	—	45.5
61	Loma Linda University Cancer CenterLoma Linda, CA		—	—	45.5
62	Tampa General Hospital Cancer InstituteTampa, FL		—	—	45.5
63	Princess Margaret Cancer CentreToronto, ON		—	—	45.5
64	BC CancerVancouver, BC		—	—	45.5

Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →